Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com

Europe Rabeprazole Sodium Market Size, Share & Trends Analysis Report By Age, By Distribution Channel (Drug & Retail Store Pharmacies, Hospital Pharmacies and Online Pharmacies), By Application, By Country and Growth Forecast, 2024 - 2031

Published Date : 09-Jul-2024

Pages: 99

Formats: PDF

The Europe Rabeprazole Sodium Market would witness market growth of 3.3% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Rabeprazole Sodium Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $50,269.2 Thousands by 2031. The UK market is exhibiting a CAGR of 2.4% during (2024 - 2031). Additionally, The France market would experience a CAGR of 4.2% during (2024 - 2031).

Europe Rabeprazole Sodium Market

Managing H. pylori infections typically involves a multidisciplinary approach, combining antibiotic therapy with acid suppression using PPIs like rabeprazole sodium. This dual treatment strategy targets the bacterium and the underlying gastric acidity that promotes its survival and colonization.

Additionally, by reducing stomach acid production, rabeprazole sodium creates an environment less conducive to H. pylori growth, enhancing antibiotic therapy's effectiveness and improving patient treatment outcomes.

The expanding market for rabeprazole sodium is driven by the demand for effective treatments for conditions such as gastroesophageal reflux disease (GERD) and peptic ulcers in a variety of European nations. The market dynamics are influenced by diverse factors unique to each country, including dietary habits, lifestyle choices, and healthcare policies. In Germany, the market is propelled by the high prevalence of GERD and other gastrointestinal disorders. According to the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS), GERD affects approximately 15-20% of the population.

Free Valuable Insights: The Global Rabeprazole Sodium Market will Hit USD 845.3 Million by 2031, at a CAGR of 3.7%

Based on Age, the market is segmented into Below 55 years and Above 55 years. Based on Distribution Channel, the market is segmented into Drug & Retail Store Pharmacies, Hospital Pharmacies and Online Pharmacies. Based on Application, the market is segmented into Gastroesophageal Reflux Disease, Peptic Ulcer and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

  • Cipla Limited
  • Sun Pharmaceutical Industries Ltd.
  • Intas Pharmaceuticals Ltd.
  • Reddy’s Laboratories Ltd.
  • Cadila Pharmaceuticals Ltd
  • Alembic Pharmaceuticals Ltd
  • Woodward Pharma
  • Elikem Pharmaceuticals Pvt Ltd
  • Jasco Labs Private Limited
  • Torrent Pharmaceuticals Ltd.

Europe Rabeprazole Sodium Market Report Segmentation

By Age

  • Below 55 years and
  • Above 55 years

By Distribution Channel

  • Drug & Retail Store Pharmacies,
  • Hospital Pharmacies and
  • Online Pharmacies

By Application

  • Gastroesophageal Reflux Disease,
  • Peptic Ulcer and
  • Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Rabeprazole Sodium Market, by Age
1.4.2 Europe Rabeprazole Sodium Market, by Distribution Channel
1.4.3 Europe Rabeprazole Sodium Market, by Application
1.4.4 Europe Rabeprazole Sodium Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Europe Rabeprazole Sodium Market by Age
4.1 Europe Below 55 years Market by Country
4.2 Europe Above 55 years Market by Country

Chapter 5. Europe Rabeprazole Sodium Market by Distribution Channel
5.1 Europe Drug & Retail Store Pharmacies Market by Country
5.2 Europe Hospital Pharmacies Market by Country
5.3 Europe Online Pharmacies Market by Country

Chapter 6. Europe Rabeprazole Sodium Market by Application
6.1 Europe Gastroesophageal Reflux Disease Market by Country
6.2 Europe Peptic Ulcer Market by Country
6.3 Europe Others Market by Country

Chapter 7. Europe Rabeprazole Sodium Market by Country
7.1 Germany Rabeprazole Sodium Market
7.1.1 Germany Rabeprazole Sodium Market by Age
7.1.2 Germany Rabeprazole Sodium Market by Distribution Channel
7.1.3 Germany Rabeprazole Sodium Market by Application
7.2 UK Rabeprazole Sodium Market
7.2.1 UK Rabeprazole Sodium Market by Age
7.2.2 UK Rabeprazole Sodium Market by Distribution Channel
7.2.3 UK Rabeprazole Sodium Market by Application
7.3 France Rabeprazole Sodium Market
7.3.1 France Rabeprazole Sodium Market by Age
7.3.2 France Rabeprazole Sodium Market by Distribution Channel
7.3.3 France Rabeprazole Sodium Market by Application
7.4 Russia Rabeprazole Sodium Market
7.4.1 Russia Rabeprazole Sodium Market by Age
7.4.2 Russia Rabeprazole Sodium Market by Distribution Channel
7.4.3 Russia Rabeprazole Sodium Market by Application
7.5 Spain Rabeprazole Sodium Market
7.5.1 Spain Rabeprazole Sodium Market by Age
7.5.2 Spain Rabeprazole Sodium Market by Distribution Channel
7.5.3 Spain Rabeprazole Sodium Market by Application
7.6 Italy Rabeprazole Sodium Market
7.6.1 Italy Rabeprazole Sodium Market by Age
7.6.2 Italy Rabeprazole Sodium Market by Distribution Channel
7.6.3 Italy Rabeprazole Sodium Market by Application
7.7 Rest of Europe Rabeprazole Sodium Market
7.7.1 Rest of Europe Rabeprazole Sodium Market by Age
7.7.2 Rest of Europe Rabeprazole Sodium Market by Distribution Channel
7.7.3 Rest of Europe Rabeprazole Sodium Market by Application

Chapter 8. Company Profiles
8.1 Cadila Pharmaceutical Limited
8.1.1 Company Overview
8.2 Alembic Pharmaceuticals Ltd. (Alembic Group)
8.2.1 Company Overview
8.3 Woodward Pharma Services
8.3.1 Company Overview
8.4 Elikem Pharmaceuticals Pvt. Ltd.
8.4.1 Company Overview
8.5 Jasco Labs Pvt Ltd
8.5.1 Company Overview
8.6 Torrent Pharmaceuticals Ltd.
8.6.1 Company Overview
8.7 Cipla Limited
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Sun Pharmaceutical Industries Ltd.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 SWOT Analysis
8.9 Intas Pharmaceutical Ltd.
8.9.1 Company Overview
8.10. Dr. Reddy’s Laboratories Ltd.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expense
8.10.5 SWOT Analysis
TABLE 1 Europe Rabeprazole Sodium Market, 2020 - 2023, USD Thousands
TABLE 2 Europe Rabeprazole Sodium Market, 2024 - 2031, USD Thousands
TABLE 3 Europe Rabeprazole Sodium Market by Age, 2020 - 2023, USD Thousands
TABLE 4 Europe Rabeprazole Sodium Market by Age, 2024 - 2031, USD Thousands
TABLE 5 Europe Below 55 years Market by Country, 2020 - 2023, USD Thousands
TABLE 6 Europe Below 55 years Market by Country, 2024 - 2031, USD Thousands
TABLE 7 Europe Above 55 years Market by Country, 2020 - 2023, USD Thousands
TABLE 8 Europe Above 55 years Market by Country, 2024 - 2031, USD Thousands
TABLE 9 Europe Rabeprazole Sodium Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 10 Europe Rabeprazole Sodium Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 11 Europe Drug & Retail Store Pharmacies Market by Country, 2020 - 2023, USD Thousands
TABLE 12 Europe Drug & Retail Store Pharmacies Market by Country, 2024 - 2031, USD Thousands
TABLE 13 Europe Hospital Pharmacies Market by Country, 2020 - 2023, USD Thousands
TABLE 14 Europe Hospital Pharmacies Market by Country, 2024 - 2031, USD Thousands
TABLE 15 Europe Online Pharmacies Market by Country, 2020 - 2023, USD Thousands
TABLE 16 Europe Online Pharmacies Market by Country, 2024 - 2031, USD Thousands
TABLE 17 Europe Rabeprazole Sodium Market by Application, 2020 - 2023, USD Thousands
TABLE 18 Europe Rabeprazole Sodium Market by Application, 2024 - 2031, USD Thousands
TABLE 19 Europe Gastroesophageal Reflux Disease Market by Country, 2020 - 2023, USD Thousands
TABLE 20 Europe Gastroesophageal Reflux Disease Market by Country, 2024 - 2031, USD Thousands
TABLE 21 Europe Peptic Ulcer Market by Country, 2020 - 2023, USD Thousands
TABLE 22 Europe Peptic Ulcer Market by Country, 2024 - 2031, USD Thousands
TABLE 23 Europe Others Market by Country, 2020 - 2023, USD Thousands
TABLE 24 Europe Others Market by Country, 2024 - 2031, USD Thousands
TABLE 25 Europe Rabeprazole Sodium Market by Country, 2020 - 2023, USD Thousands
TABLE 26 Europe Rabeprazole Sodium Market by Country, 2024 - 2031, USD Thousands
TABLE 27 Germany Rabeprazole Sodium Market, 2020 - 2023, USD Thousands
TABLE 28 Germany Rabeprazole Sodium Market, 2024 - 2031, USD Thousands
TABLE 29 Germany Rabeprazole Sodium Market by Age, 2020 - 2023, USD Thousands
TABLE 30 Germany Rabeprazole Sodium Market by Age, 2024 - 2031, USD Thousands
TABLE 31 Germany Rabeprazole Sodium Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 32 Germany Rabeprazole Sodium Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 33 Germany Rabeprazole Sodium Market by Application, 2020 - 2023, USD Thousands
TABLE 34 Germany Rabeprazole Sodium Market by Application, 2024 - 2031, USD Thousands
TABLE 35 UK Rabeprazole Sodium Market, 2020 - 2023, USD Thousands
TABLE 36 UK Rabeprazole Sodium Market, 2024 - 2031, USD Thousands
TABLE 37 UK Rabeprazole Sodium Market by Age, 2020 - 2023, USD Thousands
TABLE 38 UK Rabeprazole Sodium Market by Age, 2024 - 2031, USD Thousands
TABLE 39 UK Rabeprazole Sodium Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 40 UK Rabeprazole Sodium Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 41 UK Rabeprazole Sodium Market by Application, 2020 - 2023, USD Thousands
TABLE 42 UK Rabeprazole Sodium Market by Application, 2024 - 2031, USD Thousands
TABLE 43 France Rabeprazole Sodium Market, 2020 - 2023, USD Thousands
TABLE 44 France Rabeprazole Sodium Market, 2024 - 2031, USD Thousands
TABLE 45 France Rabeprazole Sodium Market by Age, 2020 - 2023, USD Thousands
TABLE 46 France Rabeprazole Sodium Market by Age, 2024 - 2031, USD Thousands
TABLE 47 France Rabeprazole Sodium Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 48 France Rabeprazole Sodium Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 49 France Rabeprazole Sodium Market by Application, 2020 - 2023, USD Thousands
TABLE 50 France Rabeprazole Sodium Market by Application, 2024 - 2031, USD Thousands
TABLE 51 Russia Rabeprazole Sodium Market, 2020 - 2023, USD Thousands
TABLE 52 Russia Rabeprazole Sodium Market, 2024 - 2031, USD Thousands
TABLE 53 Russia Rabeprazole Sodium Market by Age, 2020 - 2023, USD Thousands
TABLE 54 Russia Rabeprazole Sodium Market by Age, 2024 - 2031, USD Thousands
TABLE 55 Russia Rabeprazole Sodium Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 56 Russia Rabeprazole Sodium Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 57 Russia Rabeprazole Sodium Market by Application, 2020 - 2023, USD Thousands
TABLE 58 Russia Rabeprazole Sodium Market by Application, 2024 - 2031, USD Thousands
TABLE 59 Spain Rabeprazole Sodium Market, 2020 - 2023, USD Thousands
TABLE 60 Spain Rabeprazole Sodium Market, 2024 - 2031, USD Thousands
TABLE 61 Spain Rabeprazole Sodium Market by Age, 2020 - 2023, USD Thousands
TABLE 62 Spain Rabeprazole Sodium Market by Age, 2024 - 2031, USD Thousands
TABLE 63 Spain Rabeprazole Sodium Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 64 Spain Rabeprazole Sodium Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 65 Spain Rabeprazole Sodium Market by Application, 2020 - 2023, USD Thousands
TABLE 66 Spain Rabeprazole Sodium Market by Application, 2024 - 2031, USD Thousands
TABLE 67 Italy Rabeprazole Sodium Market, 2020 - 2023, USD Thousands
TABLE 68 Italy Rabeprazole Sodium Market, 2024 - 2031, USD Thousands
TABLE 69 Italy Rabeprazole Sodium Market by Age, 2020 - 2023, USD Thousands
TABLE 70 Italy Rabeprazole Sodium Market by Age, 2024 - 2031, USD Thousands
TABLE 71 Italy Rabeprazole Sodium Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 72 Italy Rabeprazole Sodium Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 73 Italy Rabeprazole Sodium Market by Application, 2020 - 2023, USD Thousands
TABLE 74 Italy Rabeprazole Sodium Market by Application, 2024 - 2031, USD Thousands
TABLE 75 Rest of Europe Rabeprazole Sodium Market, 2020 - 2023, USD Thousands
TABLE 76 Rest of Europe Rabeprazole Sodium Market, 2024 - 2031, USD Thousands
TABLE 77 Rest of Europe Rabeprazole Sodium Market by Age, 2020 - 2023, USD Thousands
TABLE 78 Rest of Europe Rabeprazole Sodium Market by Age, 2024 - 2031, USD Thousands
TABLE 79 Rest of Europe Rabeprazole Sodium Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 80 Rest of Europe Rabeprazole Sodium Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 81 Rest of Europe Rabeprazole Sodium Market by Application, 2020 - 2023, USD Thousands
TABLE 82 Rest of Europe Rabeprazole Sodium Market by Application, 2024 - 2031, USD Thousands
TABLE 83 Key Information –Cadila Pharmaceutical LimitedXX
TABLE 84 Key Information – Alembic Pharmaceuticals Ltd.
TABLE 85 Key Information – Woodward Pharma Services
TABLE 86 Key Information – Elikem Pharmaceuticals Pvt. Ltd.
TABLE 87 Key Information – Jasco Labs Pvt. Ltd.
TABLE 88 Key Information – Torrent Pharmaceuticals Ltd.
TABLE 89 Key Information – Cipla Limited
TABLE 90 Key Information – Sun Pharmaceutical Industries Ltd.
TABLE 91 Key Information – Intas Pharmaceutical Ltd.
TABLE 92 Key Information – Dr. Reddy’s Laboratories Ltd.

List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Rabeprazole Sodium Market, 2020 - 2031, USD Thousands
FIG 3 Key Factors Impacting rabeprazole sodium Market
FIG 4 Porter’s Five Forces Analysis – Rabeprazole Sodium Market
FIG 5 Europe Rabeprazole Sodium Market share by Age, 2023
FIG 6 Europe Rabeprazole Sodium Market share by Age, 2031
FIG 7 Europe Rabeprazole Sodium Market by Age, 2020 - 2031, USD Thousands
FIG 8 Europe Rabeprazole Sodium Market share by Distribution Channel, 2023
FIG 9 Europe Rabeprazole Sodium Market share by Distribution Channel, 2031
FIG 10 Europe Rabeprazole Sodium Market by Distribution Channel, 2020 - 2031, USD Thousands
FIG 11 Europe Rabeprazole Sodium Market share by Application, 2023
FIG 12 Europe Rabeprazole Sodium Market share by Application, 2031
FIG 13 Europe Rabeprazole Sodium Market by Application, 2020 - 2031, USD Thousands
FIG 14 Europe Rabeprazole Sodium Market share by Region, 2023
FIG 15 Europe Rabeprazole Sodium Market share by region, 2031
FIG 16 Europe Rabeprazole Sodium Market by Region, 2020 - 2031, USD Thousands
FIG 17 SWOT Analysis: Cipla Limited
FIG 18 SWOT Analysis: Sun Pharmaceutical Industries Ltd.
FIG 19 SWOT Analysis: Dr. Reddy’s Laboratories Ltd.

Purchase Full Report of
Europe Rabeprazole Sodium Market

Buy Now

Avail up to 60% discount on subscription plans on

SUBSCRIPTION MODEL